Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy-Reference-Cited by-同舟云学术

Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy

Published:2011-02 Issue:1 Volume:23 Page:24-30
ISSN:1040-872X
Container-title:Current Opinion in Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Tsujioka Hiroshi,Yotsumoto Fusanori,Hikita Shoko,Ueda Taeko,Kuroki Masahide,Miyamoto Shingo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference53 articles.

1. Ovarian cancer: an update on genetics and therapy;Penson;Compr Ther,1998

2. A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action;Mills;Cancer Res,1988

3. Mechanisms of transcoelomic metastasis in ovarian cancer;Tan;Lancet Oncol,2006

4. Malignant effusions contain lysophosphatidic acid (LPA)-like activity;Westermann;Ann Oncol,1998

5. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients;Xu;Clin Cancer Res,1995

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia;Genome Medicine;2023-10-16

2. AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy;International Journal of Molecular Sciences;2023-07-07

3. The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review;Journal of Cancer Research and Clinical Oncology;2022-09-02

4. MicroRNA‑409‑5p inhibits cell proliferation, and induces G₂/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells;Oncology Letters;2022-06-14

5. ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer;Cancers;2021-11-06